What is CAS 71368-80-4?

What is CAS 71368-80-4?

CAS 71368-80-4 is a compound called bromazolam. It is classified as a newer benzodiazepine, which means it has unique chemical properties compared to traditional benzodiazepines like alprazolam and diazepam. Although it was first synthesized in 1976, it was never commercially available and was not known until recently.

Bromazolam Classified as a New Class of Benzodiazepines

Because of its unique chemical structure, bromazolam is classified as a new class of benzodiazepines. Benzodiazepines are a class of psychoactive drugs that act as central nervous system depressants and are known for their sedative, hypnotic, and anxiolytic effects. Over time, traditional benzodiazepines have become the drug of choice for the treatment of anxiety and sleep disorders, but they have some adverse side effects such as addiction, withdrawal and cognitive impairment.

However, newer benzodiazepines like bromazolam aim to address these issues by retaining the desired effects without the side effects. Bromazolam has been found to have potent sedative and anxiolytic effects, making it an ideal drug for the treatment of anxiety and sleep disorders.

describe

Bromazolam is classified as a new class of benzodiazepines, first synthesized in 1976 but never marketed. It was subsequently marketed as a specialty drug and was initially identified by the Swedish EMCDDA in 2016. Bromazolam is the bromine analog of alprazolam, with bromine replacing the chlorine. Furthermore, it shares structural similarities with traditional benzodiazepines such as alprazolam and bromazepam, making it a promising alternative.

It is a psychotropic drug and central nervous system depressant that causes sedation and relaxation. Its effects depend on the dosage and the individual’s general health, kidney and liver function, and mental state. Bromazolam is estimated to have a relatively long half-life, which contributes to its prolonged duration of action.

use

As a designer drug, bromazolam has been used recreationally and medically. Its sedative and anxiolytic properties make it ideal for treating anxiety and sleep disorders. It has been used to treat anxiety, restlessness, agitation, insomnia, depression, and several other mood disorders. It works quickly and can help individuals relax and fall asleep faster.

Mazolam bromide has been found to be effective in the treatment of some neurological disorders affecting the central nervous system. Some of these neurological disorders include tremors, seizures, and focal dystonia.

The use of bromazolam is regulated in many countries because of its potential for abuse. It is sold as a specialty drug, making it difficult to control its distribution and use.

side effect

Bromazolam has certain side effects, mainly depending on the dose and individual health status. Some side effects include drowsiness, fatigue, dizziness, memory disturbance, ataxia, and confusion. Long-term use of bromazolam can lead to addiction, dependence and tolerance. Stopping the drug suddenly can cause withdrawal symptoms.

in conclusion

Bromazolam is a novel benzodiazepine that is classified as a new class of benzodiazepines. It has similar sedative and anxiolytic effects to traditional benzodiazepines like alprazolam, but with fewer side effects. Mazolam bromide has been found to be effective in the treatment of anxiety, sleep disorders, and some neurological disorders. Its use is regulated in many countries because of its potential for abuse. If you are experiencing anxiety or sleep disturbances, it is important to consult your physician for appropriate treatment options.